Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

The FDA rejected the company’s initial NDA in 2021, citing the lack of an adequate trial to demonstrate efficacy.

The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre at Ahmedabad, in the Indian state ...

Disc Medicine finalised the pivotal Phase III trial design of bitopertin in erythropoietic protoporphyria (EPP) with the FDA ...

Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal ...

Cellipont and Secretome Therapeutics are set to enter a collaboration for the manufacturing of the latter’s cellular therapy, ...

The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...

Adaptive logistics are vital for clinical trials, but there are challenges in navigating complexities of regulations and ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...